Yosuke Kito

672 total citations
40 papers, 325 citations indexed

About

Yosuke Kito is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Yosuke Kito has authored 40 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 15 papers in Surgery. Recurrent topics in Yosuke Kito's work include Gastric Cancer Management and Outcomes (25 papers), Colorectal Cancer Treatments and Studies (17 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Yosuke Kito is often cited by papers focused on Gastric Cancer Management and Outcomes (25 papers), Colorectal Cancer Treatments and Studies (17 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Yosuke Kito collaborates with scholars based in Japan, United States and France. Yosuke Kito's co-authors include Hirofumi Yasui, Kentaro Yamazaki, Nozomu Machida, Yukio Yoshida, Yusuke Onozawa, Takahiro Tsushima, Akira Fukutomi, Tomoya Yokota, Satoshi Hamauchi and Akiko Todaka and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Yosuke Kito

33 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yosuke Kito Japan 10 218 134 119 70 31 40 325
Kenji Maki Japan 8 131 0.6× 174 1.3× 107 0.9× 14 0.2× 50 1.6× 30 330
Minami Hashimoto Japan 9 132 0.6× 152 1.1× 111 0.9× 43 0.6× 18 0.6× 59 267
Kyung Ho Pak South Korea 12 174 0.8× 113 0.8× 70 0.6× 111 1.6× 44 1.4× 19 307
Wobbe O. de Steur Netherlands 14 408 1.9× 247 1.8× 127 1.1× 161 2.3× 17 0.5× 26 509
Wen‐Hu Hsu Taiwan 11 184 0.8× 126 0.9× 28 0.2× 42 0.6× 43 1.4× 18 320
Benjamin R. Alsop United States 7 295 1.4× 374 2.8× 76 0.6× 60 0.9× 66 2.1× 15 458
Tomasz Skoczylas Poland 11 283 1.3× 227 1.7× 208 1.7× 123 1.8× 21 0.7× 41 414
Guido Missale Italy 10 193 0.9× 325 2.4× 87 0.7× 111 1.6× 32 1.0× 23 424
Jean‐Michel Balon France 6 275 1.3× 307 2.3× 62 0.5× 13 0.2× 54 1.7× 8 398
Yin‐Yi Chu Taiwan 12 141 0.6× 209 1.6× 49 0.4× 68 1.0× 38 1.2× 24 300

Countries citing papers authored by Yosuke Kito

Since Specialization
Citations

This map shows the geographic impact of Yosuke Kito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosuke Kito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosuke Kito more than expected).

Fields of papers citing papers by Yosuke Kito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yosuke Kito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosuke Kito. The network helps show where Yosuke Kito may publish in the future.

Co-authorship network of co-authors of Yosuke Kito

This figure shows the co-authorship network connecting the top 25 collaborators of Yosuke Kito. A scholar is included among the top collaborators of Yosuke Kito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yosuke Kito. Yosuke Kito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsuji, Kunihiro, et al.. (2025). A case of zolbetuximab-induced protein-losing gastroenteropathy in a patient with advanced gastric cancer. International Cancer Conference Journal. 14(3). 269–273.
2.
Sunakawa, Yu, Yasuhiro Sakamoto, Ryohei Kawabata, et al.. (2024). Tumor Response Predicts Survival Time of Nivolumab Monotherapy for Advanced Gastric Cancer: A Subgroup Analysis of the DELIVER Trial (JACCRO GC-08). The Oncologist. 29(8). e997–e1002. 3 indexed citations
3.
Kawabata, Ryohei, Daisuke Sakai, Shigenori Kadowaki, et al.. (2024). Subgroup analyses of the effect of ramucirumab in pretreatment with immune checkpoint inhibitor in RINDBeRG: A randomized clinical trial in third- or further-line treatment of gastric cancer.. Journal of Clinical Oncology. 42(3_suppl). 339–339. 2 indexed citations
4.
Kito, Yosuke, Hisato Kawakami, Seiichiro Mitani, et al.. (2023). Trifluridine/Tipiracil Plus Bevacizumab for Vulnerable Patients With Pretreated Metastatic Colorectal Cancer: A Retrospective Study (WJOG14520G). The Oncologist. 29(3). e330–e336. 5 indexed citations
5.
Mitani, Seiichiro, Yosuke Kito, Kentaro Kawakami, et al.. (2023). Real-World Treatment Sequencing in Vulnerable Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Study. Targeted Oncology. 18(5). 707–715. 2 indexed citations
6.
7.
8.
Takahashi, Yoshikazu, Yu Sunakawa, Eisuke Inoue, et al.. (2021). Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08). Gastric Cancer. 25(1). 235–244. 23 indexed citations
9.
Tsuji, Kunihiro, Yosuke Kito, Naohiro Yoshida, et al.. (2020). Colitis induced by Lenvatinib in a patient with advanced hepatocellular carcinoma. Clinical Journal of Gastroenterology. 14(1). 187–192. 5 indexed citations
10.
Tsuji, Kunihiro, et al.. (2020). Docetaxel-induced fluid retention during adjuvant chemotherapy with S-1 plus docetaxel. Clinical Journal of Gastroenterology. 14(1). 84–87.
11.
Kito, Yosuke, Hironaga Satake, Hiroya Taniguchi, et al.. (2020). Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. 86(2). 277–284. 4 indexed citations
12.
Kawakami, Takeshi, Takahiro Tsushima, Katsuhiro Omae, et al.. (2018). Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study. BMC Cancer. 18(1). 573–573. 40 indexed citations
13.
Narita, Yukiya, Shigenori Kadowaki, Isao Oze, et al.. (2018). Establishment and validation of prognostic nomograms in first-line metastatic gastric cancer patients. Journal of Gastrointestinal Oncology. 9(1). 52–63. 30 indexed citations
14.
Shirasu, Hiromichi, Takahiro Tsushima, S. Kawai, et al.. (2017). Role of hepatectomy in gastric cancer with multiple liver-limited metastases. Gastric Cancer. 21(2). 338–344. 31 indexed citations
15.
16.
17.
Yoshida, Yukio, Akira Fukutomi, Masaki Tanaka, et al.. (2017). Gastrojejunostomy versus duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer. Pancreatology. 17(6). 983–989. 30 indexed citations
18.
Kawakami, Takeshi, Nozomu Machida, Hirofumi Yasui, et al.. (2016). Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 78(4). 809–814. 28 indexed citations
19.
Taniguchi, Hiroya, Yosuke Kito, Satoshi Hamauchi, et al.. (2015). 169P Serum CA19-9 response is an early predictive marker for the efficacy of regorafenib in refractory metastatic colorectal cancer. Annals of Oncology. 26. ix42–ix42.
20.
Takeda, Yasuhito, Kunihiro Tsuji, Yoshiro Asahina, et al.. (2013). Sa1134 Does Long-Term Use of Proton Pump Inhibitors Cause Hypomagnesemia?. Gastroenterology. 144(5). S–210.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenji Maki Breakdown of academic impact, for papers by Minami Hashimoto Breakdown of academic impact, for papers by Kyung Ho Pak Breakdown of academic impact, for papers by Wobbe O. de Steur Breakdown of academic impact, for papers by Wen‐Hu Hsu Breakdown of academic impact, for papers by Benjamin R. Alsop Breakdown of academic impact, for papers by Tomasz Skoczylas Breakdown of academic impact, for papers by Guido Missale Breakdown of academic impact, for papers by Jean‐Michel Balon Breakdown of academic impact, for papers by Yin‐Yi Chu
Rankless by CCL
2026